Table 7.
Total annual direct healthcare cost (at 2014–2015 prices) of managing nocturia in Germany, Sweden, and the UK
| Total direct annual healthcare costs attributable to managing nocturia | ||||||
|---|---|---|---|---|---|---|
| Germany (€) | Sweden (kr) | UK (£) | ||||
| Clinician visits | 244,625,051 (11 %) | 3,072,586,752 (60 %) | 795,517,872 (59 %) | |||
| Prescribed drugs | 472,403,515 (20 %) | 194,126,227 (4 %) | 137,443,084 (10 %) | |||
| Over-the-counter drugs | 37,607,278 (2 %) | 0 (0 %) | 0 (0 %) | |||
| Diagnostic tests | 0 (0 %) | 180,073,118 (4 %) | 1,398,160 (0 %) | |||
| Hospitalization | 453,083,943 (20 %) | 313,770,214 (6 %) | 110,934,067 (8 %) | |||
| Falls and fractures | 1,108,709,552 (48 %) | 1,352,870,393 (26 %) | 308,963,298 (23 %) | |||
| Total direct cost | 2,316,429,339 (100 %) | 5,113,426,704 (100 %) | 1,354,256,481 (100 %) | |||
| Total direct cost per patient | 185 | 4215 | 157 | |||
| Total direct cost per capita | 29 | 525 | 21 | |||
1 kr ≈ €0.11, £1 ≈ €1.31. Percentage of total cost in parentheses